FILGOTINIB, A SELECTIVE JANUS KINASE 1 (JAK1) INHIBITOR, MODULATES DISEASE-ASSOCIATED CYTOKINES IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS

Taylor, PC; Elboudwarej, E; Li, WY; Hawtin, RE; Liu, J; Mirza, AM

ANNALS OF THE RHEUMATIC DISEASES, 2019; 78 (): 736